Cargando…
Cisatracurium-besilate: ICU-acquired weakness: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184325/ http://dx.doi.org/10.1007/s40278-022-16973-9 |
Ejemplares similares
-
Baricitinib/cisatracurium besilate: Rhabdomyolysis: case report
Publicado: (2021) -
Continuously protracted infusion of cisatracurium besilate in patients with ARDS
por: Yuan, Ziming, et al.
Publicado: (2022) -
Cisatracurium besilate/dexamethasone/remdesivir: Malignant hyperthermia and lack of efficacy: case report
Publicado: (2021) -
Cisatracurium besilate enhances the TRAIL-induced apoptosis of gastric cancer cells via p53 signaling
por: Zhou, Qiang, et al.
Publicado: (2021) -
Facial Nerve Monitoring under Different Levels of Neuromuscular Blockade with Cisatracurium Besilate in Parotid Tumour Surgery
por: Huang, Huimin, et al.
Publicado: (2021)